Aravive Inc (NASDAQ:ARAV)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - ARAV
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ARAV
- Market Cap$93.310m
- SymbolNASDAQ:ARAV
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS03890D1081
Company Profile
Aravive Inc is a clinical-stage biotechnology company. It focuses on developing therapies that target important survival pathways for both solid tumors as well as hematologic malignancies. The company's lead candidate AVB-500 is developed as a targeted therapy against ovarian cancer.Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.
Latest ARAV news
Currently there for this company. Visit our news hub for other news .